Home Newsfeeds Stifel Maintains Buy on MSA Safety, Raises Price Target to $170

Stifel Maintains Buy on MSA Safety, Raises Price Target to $170

Stifel analyst Stanley Elliott maintains MSA Safety (NYSE:MSA) with a Buy and raises the price target from $157 to $170.

byBenzinga Newsdesk

December 19, 2022

1 minute read

Stifel analyst Stanley Elliott maintains MSA Safety (NYSE:MSA) with a Buy and raises the price target from $157 to $170.

Tesla Bear Gordon Johnson Accuses NHTSA Of Being ‘Bought And Paid For’ Over Model 3, Model Y ‘Phantom-Braking’ Woes

By Anan Ashraf

December 7, 6:50 AM

A post claimed that complaints about Tesla's phantom braking "drastically increased" following CEO Elon Musk's decision to disable radar on all Model 3 and Model Y cars.

TSLA

Lexaria’s Plans To Study Weight Loss And Diabetes Control In A Human Clinical Study With DehydraTECH-CBD

By Happy Mohamed

August 2, 9:14 AM

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to report its intention to conduct a human clinical study to

LEXX

Stitch Fix Stock Flashes Bullish Technical Indicators Ahead Of Q3 Earnings

By Surbhi Jain

June 4, 9:25 AM

Stitch Fix (SFIX) will report its Q3 earnings with expected EPS of -23 cents and $306.12 million in revenue. Despite fluctuations, investors and analysts have a positive outlook on the personalized clothing company's growth potential.

SFIX

Wells Fargo Maintains Overweight on Kilroy Realty, Lowers Price Target to $57

By Benzinga Newsdesk

August 30, 8:02 AM

Wells Fargo analyst Blaine Heck maintains Kilroy Realty (NYSE:KRC) with a Overweight and lowers the price target from $60 to $57.

KRC

Stifel Maintains Buy on MSA Safety, Raises Price Target to $170

Related Posts

Tesla Bear Gordon Johnson Accuses NHTSA Of Being ‘Bought And Paid For’ Over Model 3, Model Y ‘Phantom-Braking’ Woes

Lexaria’s Plans To Study Weight Loss And Diabetes Control In A Human Clinical Study With DehydraTECH-CBD

Stitch Fix Stock Flashes Bullish Technical Indicators Ahead Of Q3 Earnings

Wells Fargo Maintains Overweight on Kilroy Realty, Lowers Price Target to $57